Chatman v. Wynn

CourtDistrict Court, S.D. Illinois
DecidedOctober 22, 2024
Docket3:23-cv-03465
StatusUnknown

This text of Chatman v. Wynn (Chatman v. Wynn) is published on Counsel Stack Legal Research, covering District Court, S.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Chatman v. Wynn, (S.D. Ill. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF ILLINOIS

JAMES CHATMAN, B24332, ) ) Plaintiff, ) ) vs. ) ) Case No. 23-cv-3465-DWD DR. WYNN1 and ) WEXFORD HEALTH SOURCES, INC., ) ) Defendants. )

MEMORANDUM AND ORDER

DUGAN, District Judge: Plaintiff James Chatman, an inmate of the Illinois Department of Corrections (IDOC) currently incarcerated at Pinckneyville Correctional Center (“Pinckneyville”), brings this action pursuant to 42 U.S.C. § 1983 for alleged deprivations of his constitutional rights. Plaintiff alleged that Dr. Wynn, now identified as Zaw Win, M.D., was deliberately indifferent to his medical situation by prescribing medication that caused or worsened other medical issues and by refusing to discontinue it, and that Wexford contributed to this harm by maintaining a policy or practice of using medications to cut costs instead of referring individuals to medical specialists. Defendants filed a Motion for Summary Judgment (Docs. 26, 27) on the issue of whether Plaintiff exhausted his administrative remedies prior to filing this lawsuit, as required by the Prison Litigation Reform Act, 42 U.S.C. § 1997e(a). After a volley of responses and

1 The Clerk of Court is DIRECTED to update the docket sheet to reflect Dr. Wynn’s name as Zaw Win, M.D.. (Doc. 20). replies (Docs. 31, 32, 33, 34, 35), the matter is now ripe for consideration. For reasons explained, Defendants’ Motion is granted, and this matter is dismissed without prejudice. BACKGROUND

Plaintiff initiated this lawsuit by filing a Complaint on October 22, 2023. (Doc. 1 at 16). In the Complaint, Plaintiff alleged that in February of 2022 he experienced kidney failure and other medical emergencies that required a week-long hospitalization. Prior to being hospitalized, he had complained to Dr. Win about side effects of mediations that were being used to treat Tardive Dyskinesia and he had asked to have the medications

discontinued, but Dr. Win refused. He claims that Dr. Win’s refusal was part of a bigger cost-cutting policy that Wexford maintains, which requires that an inmate be given medications before he can be seen by a specialist. He also alleges Wexford is at fault for distributing medication in packaging that does not explain the side effects. He claims he eventually learned that the medications he had complained about to Dr. Win were the

cause of his February 2022 medical emergency. Upon initial review, the Court allowed the following claims to proceed: Claim 1: Eighth Amendment deliberate indifference claim against Defendant Dr. Win for his continued use of Amantadine and Cogentin after Plaintiff complained of ill-effects;

Claim 2: Monell claim against Wexford Health Sources, Inc. for maintaining a cost cutting policy that required the use of medications over specialist visits, and a policy of failing to disclose side effects of medications;

Claim 3: Intentional infliction of emotional distress claim against Dr. Win and Wexford Health Sources, Inc. for knowingly proceeding with a harmful course of care; Claim 4: Negligence claim against Dr. Win for his treatment decisions.

(Doc. 9). The parties undertook discovery on the exhaustion of administrative remedies, and in doing so they have identified two grievances relevant to the claims in this case. Initially, Plaintiff filed a narrative response (Doc. 31) to the Motion for Summary Judgment. The Defendants then filed a reply (Doc. 32) wherein they highlighted the fact that Plaintiff had not included a response to their statement of material facts. Plaintiff filed a “response” (Doc. 33) to their reply wherein he simply highlighted the Defendants’

allegation that he did not file a proper response. On October 8, 2024, Plaintiff moved for leave to supplement his earlier responses. (Doc. 34). He included a properly formatted response to the Defendants’ statement of material facts, and he also included new legal arguments in opposition to their Motion. Defendants oppose this late “sur-reply” brief. (Doc. 35).

FINDINGS OF FACT

On April 11, 2023, Plaintiff filed grievance 1172-04-23. (Doc. 27-1 at 11-12). In this grievance he described his February 2022 hospitalization and complained that he believed it was necessitated by medications he had previously asked to discontinue due to ill-effects. On April 25, 2023, the grievance officer responded indicating that medication recommendations from the hospital were being followed and that at a recent appointment, Plaintiff was noted as improving. (Doc. 27-1 at 10). The Chief Administrative Officer (CAO) concurred with the grievance officer’s denial of the grievance on April 26, 2023. (Id.). On April 29, 2023, Plaintiff signed the denial form indicating his intent to appeal. (Id.). The Administrative Review Board (ARB) received the appeal on May 3, 2023, and on November 8, 2023, it issued a denial of the grievance,

finding the issue was appropriately addressed by the prison administration. (Doc. 27-1 at 9). On September 18, 2023, Plaintiff submitted grievance 3148-09-23. (Doc. 27-1 at 3- 4). In grievance 3148-09-23 he discussed interactions with Dr. Win concerning his prescription medications. He explained that he told Dr. Win that the medications prescribed were not helping with his Tardive Dyskinesia and he asked to be taken off of

the medications. He explained that he learned from another medical provider in September of 2023 that the medications were not actually appropriate for the treatment of Tardive Dyskinesia. He had also been told during his February 2022 hospitalization that his medications caused his medical emergency. He expressed concerns in the grievance that he may still have ill effects in his brain or kidneys, but that he has not been

examined via CAT scan or otherwise. He wrote, “PS—Wexford employee Dr. Wynn (Dr. Winn) employed cost cutting procedures which resulted in my injuries[.]” (Doc. 27-1 at 4). On September 21, 2023, a grievance officer responded and indicated Plaintiff was no longer taking any psychiatric medications and he was being seen “for his diagnosis.” (Doc. 27-1 at 2). On September 22, 2023, the CAO concurred with the denial of the

grievance, and on September 26, 2023, Plaintiff appealed. (Doc. 27-1 at 2). The appeal is stamped as received by the ARB on October 2, 2023. (Doc. 27-1 at 2). A grievance log from the ARB indicated that grievance 1172-04-23 received a “hearing date” on November 8, 2023. (Doc. 27-1 at 1). By contrast, grievance 3148-09-23 had no hearing date on the ARB log. (Doc. 27-1 at 1). Plaintiff stated in his latest response from October of 2024 (Doc. 34) that he has not yet received a response from the ARB to

grievance 3148-09-23. The Defendants indicated in their latest response (Doc. 35) that they subpoenaed records from the ARB on January 9, 2024, and got a response January 18, 2024, thus they do not have information about what has happened to any grievance pending on appeal after that date. (Doc. 35 at 5, n. 1).

CONCLUSIONS OF LAW A. Legal Standards

Summary judgment is proper if there is no genuine issue as to any material fact and the movant is entitled to judgment as a matter of law. FED. R. CIV. P. 56(a). In determining a summary judgment motion, the Court views the facts in the light most favorable to, and draws all reasonable inferences in favor of, the nonmoving party. Apex Digital, Inc. v. Sears, Roebuck & Co., 735 F.3d 962, 965 (7th Cir. 2013) (citation omitted). Courts generally cannot resolve factual disputes on a motion for summary judgment. See Tolan v. Cotton, 572 U.S.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pavey v. Conley
663 F.3d 899 (Seventh Circuit, 2011)
Frederick H. Groce v. Eli Lilly & Company
193 F.3d 496 (Seventh Circuit, 1999)
Ammons v. Gerlinger
547 F.3d 724 (Seventh Circuit, 2008)
Pavey v. Conley
544 F.3d 739 (Seventh Circuit, 2008)
Tolan v. Cotton
134 S. Ct. 1861 (Supreme Court, 2014)
Apex Digital, Incorporated v. Sears, Roebuck & Company
735 F.3d 962 (Seventh Circuit, 2013)
Joseph Wilborn v. David Ealey
881 F.3d 998 (Seventh Circuit, 2018)
Jeremy Lockett v. Tanya Bonson
937 F.3d 1016 (Seventh Circuit, 2019)
Jonathan Chambers v. Kul Sood
956 F.3d 979 (Seventh Circuit, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
Chatman v. Wynn, Counsel Stack Legal Research, https://law.counselstack.com/opinion/chatman-v-wynn-ilsd-2024.